Gandeeva Therapeutics reposted this
CEO, Gandeeva Therapeutics and Gobind Khorana Canada Excellence Research Chair, Precision Cancer Drug Design, University of British Columbia
I am delighted to be leading PROGENITER, one of the four projects that are part of #UBC-led $140M initiative to leverage BC’s academic and biosciences industry strengths to the develop novel treatments for the next viral threat to improve health outcomes for Canadians. We are excited to join forces with partners in industry including Gandeeva Therapeutics, Amgen, AbCellera, GSK and Zymeworks Inc. Thanks to Sean Silcoff and The Globe and Mail for highlighting this exciting milestone.